P. Siegel

Molecular Biology · 2003–2012

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom P. Siegel trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Massagué
  2. Yigong Shi
  3. H. Peinado

Who trusts P. Siegel overall

  1. J. Massagué
  2. D. Nguyen
  3. Ulrich Valcourt
  4. David Padua
  5. A. Moustakas
  6. X. Zhang
  7. Gerhard Christofori
  8. Alec C. Kimmelman
  9. E. Batlle
  10. C. Heldin

Papers from P. Siegel's perspective

Ordered by how strongly the researchers P. Siegel trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. (Genes & Development)
  2. Involvement of chemokine receptors in breast cancer metastasis (Nature)
  3. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. (Proceedings of the National Academy of Sciences of the United States of America)
  4. Genomic analysis of metastasis reveals an essential role for RhoC (Nature)
  5. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
  6. Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors (EMBO Journal)
  7. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. (Molecules and Cells)
  8. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. (Journal of Biological Chemistry)
  9. Gene expression profiling predicts clinical outcome of breast cancer
  10. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. (Molecular Pharmacology)

Their papers